[go: up one dir, main page]

HN1999000096A - Formulaciones intranasales para tratar trastornos sexuales - Google Patents

Formulaciones intranasales para tratar trastornos sexuales

Info

Publication number
HN1999000096A
HN1999000096A HN1999000096A HN1999000096A HN1999000096A HN 1999000096 A HN1999000096 A HN 1999000096A HN 1999000096 A HN1999000096 A HN 1999000096A HN 1999000096 A HN1999000096 A HN 1999000096A HN 1999000096 A HN1999000096 A HN 1999000096A
Authority
HN
Honduras
Prior art keywords
sexual disorders
intranasal formulations
treat sexual
treat
intranasal
Prior art date
Application number
HN1999000096A
Other languages
English (en)
Original Assignee
Pfizer Research And Development Company N V S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9813452.1A external-priority patent/GB9813452D0/en
Priority claimed from GBGB9820837.4A external-priority patent/GB9820837D0/en
Priority claimed from GBGB9903177.5A external-priority patent/GB9903177D0/en
Application filed by Pfizer Research And Development Company N V S A filed Critical Pfizer Research And Development Company N V S A
Publication of HN1999000096A publication Critical patent/HN1999000096A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A FORMULACIONES INTRANASALES PARA TRATAR TRASTORNOS SEXUALES.
HN1999000096A 1998-06-22 1999-06-15 Formulaciones intranasales para tratar trastornos sexuales HN1999000096A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9813452.1A GB9813452D0 (en) 1998-06-22 1998-06-22 Pharmaceutical formulations
GBGB9820837.4A GB9820837D0 (en) 1998-09-24 1998-09-24 Pharmaceutical formulations
GBGB9903177.5A GB9903177D0 (en) 1999-02-13 1999-02-13 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
HN1999000096A true HN1999000096A (es) 2000-12-03

Family

ID=27269368

Family Applications (1)

Application Number Title Priority Date Filing Date
HN1999000096A HN1999000096A (es) 1998-06-22 1999-06-15 Formulaciones intranasales para tratar trastornos sexuales

Country Status (40)

Country Link
US (2) US20020040139A1 (es)
EP (1) EP0967214B1 (es)
JP (1) JP3263379B2 (es)
KR (1) KR100345824B1 (es)
AP (1) AP1178A (es)
AR (1) AR016993A1 (es)
AT (1) ATE269866T1 (es)
AU (1) AU746865B2 (es)
BG (1) BG64372B1 (es)
BR (1) BR9903273A (es)
CA (1) CA2275554C (es)
CZ (1) CZ294856B6 (es)
DE (1) DE69918222T2 (es)
DK (1) DK0967214T3 (es)
DZ (1) DZ2826A1 (es)
EA (1) EA001903B1 (es)
ES (1) ES2221733T3 (es)
GT (1) GT199900095A (es)
HN (1) HN1999000096A (es)
HR (1) HRP990195B1 (es)
HU (1) HUP9902076A3 (es)
ID (1) ID23554A (es)
IL (1) IL130539A0 (es)
IS (1) IS5085A (es)
MA (1) MA25089A1 (es)
MY (1) MY117967A (es)
NO (1) NO317365B1 (es)
NZ (1) NZ336382A (es)
OA (1) OA11069A (es)
PA (1) PA8476301A1 (es)
PE (1) PE20000702A1 (es)
PT (1) PT967214E (es)
SG (1) SG77246A1 (es)
SI (1) SI0967214T1 (es)
SK (1) SK284574B6 (es)
TN (1) TNSN99129A1 (es)
TR (1) TR199901444A2 (es)
TW (1) TWI223598B (es)
UA (1) UA59385C2 (es)
YU (1) YU29699A (es)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200591B1 (en) 1998-06-25 2001-03-13 Anwar A. Hussain Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction
GB9828340D0 (en) * 1998-12-22 1999-02-17 Novartis Ag Organic compounds
CA2391968A1 (en) * 1999-11-18 2001-05-25 Natco Pharma Limited An improved pharmaceutical composition for treating male erectile dysfunction
KR20010016165A (ko) * 2000-11-16 2001-03-05 정순학 성기능 장애 치료를 위한 피부에 적용하는 제제
DE10118306A1 (de) 2001-04-12 2002-10-17 Bayer Ag Imidazotriazinonhaltige Zusammensetzungen zur nasalen Applikation
DE10118305A1 (de) * 2001-04-12 2002-10-17 Bayer Ag Zusammensetzungen zur nasalen Applikation
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
EP1392262A1 (en) 2001-05-24 2004-03-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
AU2002310086B2 (en) * 2001-05-24 2008-09-04 Alexza Pharmaceuticals, Inc. Delivery of erectile dysfunction drugs through an inhalation route
DE10248601B4 (de) * 2002-10-17 2006-05-24 Goldstein, Naum, Dr.habil.nat. Pharmazeutisches Mittel zur endonasalen Applikation bei der Behandlung von Krankheiten und Störungen des zentralen Nervensystems
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
US7138107B2 (en) * 2003-02-18 2006-11-21 Compellis Pharmaceuticals Inhibition of olfactory neurosensory function to treat eating disorders and obesity
US7638138B2 (en) * 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
USRE45404E1 (en) 2003-03-27 2015-03-03 Shin Nippon Biomedical Laboratories, Ltd. Powder medicine applicator for nasal cavity
AR043880A1 (es) * 2003-04-22 2005-08-17 Solvay Pharm Gmbh Mesilato acido de 4-(4.trans-hidroxiciclohexil) amino-2-fenil-7h-pirrolo (2,3-d) pirimidina y sus formas polimorfas
JP2007516149A (ja) 2003-05-21 2007-06-21 アレックザ ファーマシューティカルズ， インコーポレイテッド 基板温度の均一性を制御する方法、および、内蔵式加熱ユニットおよびそれを使用する薬剤供給ユニット
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
WO2006016530A1 (ja) * 2004-08-10 2006-02-16 Translational Research, Ltd. 速効性でかつ高い吸収性を可能とする経鼻投与用組成物
EP1781360A1 (en) 2004-08-12 2007-05-09 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heat packages
US20090047347A1 (en) * 2005-07-29 2009-02-19 Aegis Therapeutics, Inc. Compositions for Drug Administration
US8268791B2 (en) * 2004-08-25 2012-09-18 Aegis Therapeutics, Llc. Alkylglycoside compositions for drug administration
US20060046962A1 (en) 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
US20140162965A1 (en) 2004-08-25 2014-06-12 Aegis Therapeutics, Inc. Compositions for oral drug administration
KR101289917B1 (ko) 2004-10-18 2013-07-25 폴리문 사이언티픽 임무노이비오로기쉐 포르슝 게엠베하 평활근을 이완시키기 위한 활성 성분을 함유하는 리포좀조성물, 이런 조성물의 생산 및 이의 치료적 용도
WO2006094924A2 (en) * 2005-03-09 2006-09-14 Boehringer Ingelheim International Gmbh New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors
EA016037B1 (ru) 2005-04-19 2012-01-30 Никомед Гмбх Рофлумиласт для лечения лёгочной гипертензии
US8506934B2 (en) 2005-04-29 2013-08-13 Robert I. Henkin Methods for detection of biological substances
KR20070067173A (ko) * 2005-08-29 2007-06-27 테바 파마슈티컬 인더스트리즈 리미티드 이정점 입도 분포를 갖는 고체 미립자 타달라필
GB0526283D0 (en) * 2005-12-23 2006-02-01 Givaudan Sa Compositions
GB0606234D0 (en) * 2006-03-29 2006-05-10 Pliva Istrazivanje I Razvoj D Pharmaceutically acceptable salts and polymorphic forms
US8226949B2 (en) 2006-06-23 2012-07-24 Aegis Therapeutics Llc Stabilizing alkylglycoside compositions and methods thereof
EP2116264B1 (en) * 2006-12-26 2017-09-27 Shin Nippon Biomedical Laboratories, Ltd. Preparation for transnasal application
US8293489B2 (en) 2007-01-31 2012-10-23 Henkin Robert I Methods for detection of biological substances
EP2121088B1 (en) 2007-03-09 2016-07-13 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
DE102008004893A1 (de) 2008-01-17 2009-07-23 Add Technologies Ltd. Trägerpellets, Verfahren zu deren Herstellung und deren Verwendung
WO2009098697A1 (en) * 2008-02-08 2009-08-13 Dexxon Ltd. Modafinil and sildenafil dosage forms
CA2756690C (en) 2008-03-28 2016-08-16 Hale Biopharma Ventures, Llc Administration of benzodiazepine compositions
US8747005B2 (en) 2008-06-04 2014-06-10 Colgate-Palmolive Company Oral care implement with cavitation system
WO2009152344A2 (en) * 2008-06-11 2009-12-17 Comgenrx, Inc. Combination therapy using phosphodiesterase inhibitors
US8580801B2 (en) 2008-07-23 2013-11-12 Robert I. Henkin Phosphodiesterase inhibitor treatment
US8440631B2 (en) 2008-12-22 2013-05-14 Aegis Therapeutics, Llc Compositions for drug administration
JP2012526726A (ja) * 2009-05-15 2012-11-01 株式会社新日本科学 薬物動態が改善された鼻腔内用薬学的組成物
JP2011001317A (ja) * 2009-06-19 2011-01-06 Fumakilla Ltd 鼻用洗浄剤
WO2011013003A2 (en) * 2009-07-31 2011-02-03 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
MX344846B (es) 2010-05-10 2017-01-10 Euro-Celtique S A * Combinacion de granulos cargados activos con activos adicionales.
AU2011252040C1 (en) 2010-05-10 2015-04-02 Euro-Celtique S.A. Manufacturing of active-free granules and tablets comprising the same
PL3415139T3 (pl) 2011-06-14 2022-07-11 Neurelis, Inc. Podawanie benzodiazepiny
CN102952138B (zh) * 2011-08-17 2016-07-06 上海特化医药科技有限公司 一种吡唑并嘧啶酮化合物的盐、多晶型物及其药物组合物、制备方法和应用
GB2497933B (en) * 2011-12-21 2014-12-24 Londonpharma Ltd Drug delivery technology
WO2014055801A1 (en) * 2012-10-05 2014-04-10 Henkin Robert I Phosphodiesterase inhibitors for treating taste and smell disorders
CA2795324C (en) * 2012-11-09 2015-07-14 Purdue Pharma Pharmaceutical compositions comprising hydromorphone and naloxone
RU2536425C2 (ru) * 2013-01-17 2014-12-20 Общество с ограниченной ответственностью "Фармамед" Фармацевтическая композиция, содержащая силденафил цитрат, и способ ее приготовления
ES2744542T3 (es) * 2013-03-15 2020-02-25 Robert I Henkin Inhibidores de fosfodiesterasa para tratar trastornos gustativos y olfativos
EP3068397A1 (en) 2013-11-13 2016-09-21 Euro-Celtique S.A. Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
EP3108245B1 (en) 2014-02-18 2020-07-22 Robert I. Henkin Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell
NO2723977T3 (es) 2014-03-19 2018-03-10
US20170035764A1 (en) * 2015-08-03 2017-02-09 Synergistic Therapeutics, Llc Sexual dysfunction therapeutic gel
CN109996547A (zh) * 2016-10-31 2019-07-09 苏达有限公司 粘膜活性剂递送
CA3055094A1 (en) * 2017-03-02 2018-09-07 Dutch Renewable Energy B.V. Intranasal administration of physiologically active substances
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
SG11202006080SA (en) 2017-12-26 2020-07-29 Ftf Pharma Private Ltd Liquid oral formulations for pde v inhibitors
US12214118B2 (en) 2018-02-02 2025-02-04 Alexza Pharmaceuticals, Inc. Electrical condensation aerosol device
JP6941224B2 (ja) 2018-02-06 2021-09-29 イージス セラピューティクス，エルエルシー 疾患の処置のための鼻腔内エピネフリン製剤及び方法
WO2019200427A1 (en) 2018-04-16 2019-10-24 Barista Mist Pty Ltd Caffeine compositions and methods of use
SE542968C2 (en) * 2018-10-26 2020-09-22 Lindahl Anders Treatment of osteoarthritis
WO2022026762A1 (en) * 2020-07-29 2022-02-03 Lido Ventures Llc Apparatus, system, and method for facilitating intranasal treatment of a patient

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250534A (en) * 1990-06-20 1993-10-05 Pfizer Inc. Pyrazolopyrimidinone antianginal agents
GB9301192D0 (en) * 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
JP3348859B2 (ja) * 1995-11-20 2002-11-20 イーライ・リリー・アンド・カンパニー プロテインキナーゼｃインヒビター
CA2291256A1 (en) * 1997-05-29 1998-12-03 Mochida Pharmaceutical Co., Ltd. Therapeutic agent for erection dysfunction
CA2312839C (en) * 1997-12-02 2008-01-15 Lisbeth Illum Compositions for nasal administration
US6087368A (en) * 1998-06-08 2000-07-11 Bristol-Myers Squibb Company Quinazolinone inhibitors of cGMP phosphodiesterase

Also Published As

Publication number Publication date
CZ9902257A3 (cs) 2000-11-15
EA001903B1 (ru) 2001-10-22
DK0967214T3 (da) 2004-09-27
EA199900487A3 (ru) 2000-04-24
JP2000034232A (ja) 2000-02-02
SG77246A1 (en) 2000-12-19
NO993051D0 (no) 1999-06-21
NZ336382A (en) 1999-11-29
EP0967214A1 (en) 1999-12-29
TR199901444A2 (xx) 2000-01-21
BG64372B1 (bg) 2004-12-30
DZ2826A1 (fr) 2003-12-01
HRP990195A2 (en) 2000-02-29
IS5085A (is) 1999-12-23
DE69918222D1 (de) 2004-07-29
MA25089A1 (fr) 2000-12-31
YU29699A (sh) 2003-02-28
CA2275554C (en) 2003-06-03
BR9903273A (pt) 2000-05-09
KR20000006310A (ko) 2000-01-25
PE20000702A1 (es) 2000-08-16
TNSN99129A1 (fr) 2005-11-10
JP3263379B2 (ja) 2002-03-04
UA59385C2 (uk) 2003-09-15
HUP9902076A2 (hu) 2000-05-28
HRP990195B1 (en) 2003-04-30
AP9901585A0 (en) 1999-06-30
SK284574B6 (sk) 2005-06-02
TWI223598B (en) 2004-11-11
SK81999A3 (en) 2001-01-18
NO993051L (no) 1999-12-23
AR016993A1 (es) 2001-08-01
ID23554A (id) 2000-05-04
NO317365B1 (no) 2004-10-18
OA11069A (en) 2002-03-13
US20020040139A1 (en) 2002-04-04
CA2275554A1 (en) 1999-12-22
ATE269866T1 (de) 2004-07-15
KR100345824B1 (ko) 2002-07-24
HUP9902076A3 (en) 2002-03-28
IL130539A0 (en) 2000-06-01
GT199900095A (es) 2000-12-13
AU746865B2 (en) 2002-05-02
PT967214E (pt) 2004-08-31
US20030158206A1 (en) 2003-08-21
EP0967214B1 (en) 2004-06-23
SI0967214T1 (en) 2004-10-31
AU3579499A (en) 2000-01-06
MY117967A (en) 2004-08-30
AP1178A (en) 2003-06-30
EA199900487A2 (ru) 1999-12-29
CZ294856B6 (cs) 2005-03-16
BG103510A (en) 2000-01-31
HU9902076D0 (en) 1999-08-30
PA8476301A1 (es) 2000-09-29
DE69918222T2 (de) 2005-07-28
ES2221733T3 (es) 2005-01-01

Similar Documents

Publication Publication Date Title
HN1999000096A (es) Formulaciones intranasales para tratar trastornos sexuales
HN1999000015A (es) Tratamiento para una disfuncion sexual femenina
HN1998000132A (es) Combinaciones terapeuticas
HN1999000066A (es) Formulaciones farmaceuticas
HN1996000101A (es) Terapia combinada para la osteoporosis
HN1998000124A (es) Terapia de combinacion
HN1999000154A (es) 1,2,3,4 tetrahidroquinolinas 2 sustituidas 4 - carboxiamino sustituidas.
HN1997000126A (es) Derivados de indazol
HN1998000175A (es) Imidazotriazininas
HN1999000089A (es) Formulaciones de ziprasidona
HN1997000072A (es) Procedimiento para la preparacion de sildenafil
HN1997000058A (es) Derivados indolicos utiles para terapia
HN1997000097A (es) Piridinas condensadas con heterociclicos
HN1998000174A (es) Combinacion eficaz para el tratamiento de la impotencia
HN2001000278A (es) Procedimiento para la preparacion de imidazotriazininas substituidas con sulfonamida.
HN1998000199A (es) Agentes terapeuticos
HN1998000167A (es) Nuevo procedimiento para preparar una cetoimina
HN1998000045A (es) Composiciones farmaceuticas
HN1997000138A (es) Caramelo juguete
UY26265A1 (es) Compuestos calciolíticos
HN1998000102A (es) Composiciones solubilizadas de sertralina
HN1998000062A (es) Pirozolopirimidonas para la disfucion sexual
HN1997000147A (es) Procedimientos para piridinas sustituidas
HN1998000131A (es) Terapia de combinación
HN1999000171A (es) Concentrado oral de sertralina.